The Heart Failure and Transplant Fellowship provides inpatient and outpatient training in evaluating and treating patients with advanced heart disease, and follow-up of patients after cardiac transplant. This is a one year ACGME Accredited Fellowship Program.
Program Director
Erin Coglianese, MD
History
Our primary training facility is the Massachusetts General Hospital, a teaching hospital affiliated with the Harvard Medical School. The Mass General Hospital Heart Failure and Transplant Service was founded in 1985 and serves as a national and international resource for patients with advanced heart disease.The Mass General Hospital Heart Failure and Transplant Fellowship Program was established in 1988 with the goal of training future leaders of academic cardiology in the increasingly demanding need of cardiologists in this specialty.
Faculty
Gregory D. Lewis, MD
Medical Director of the Mass General Hospital Heart Failure and Cardiac Transplant Program. Dr. Lewis's major clinical interests are in heart failure, pulmonary hypertension and exercise physiology.
William Dean Carlson, MD, PhD
Dr. Carlson’s research has focused on the design and development of drugs for the treatment of heart failure. He has used the three dimensional structure of proteins to design and develop carvedilol, renin inhibitors and growth factor mimetics.
Chris Newton-Cheh, MD, MPH
Dr. Newton-Cheh's research seeks to identify genetic contributors to complex cardiovascular diseases including sudden cardiac death, hypertension and heart failure.
Sunu S. Thomas, MD
Dr. Thomas' clinical interests are in advanced heart failure, mechanical circulatory support, heart transplant and hemodynamics.
Jennifer E. Ho, MD
Dr. Ho's clinical interests are in cardiomyopathy, heart failure and heart transplant.
Erin E. Coglianese, MD
Dr. Coglianese's interests are in heart failure, heart transplant, mechanical circulatory support and cardiomyopathy.
Nasrien Ibrahim, MD
Dr. Ibrahim's clinical interests are in cardiology, heart failure, heart transplant, mechanical circulatory support and clinical trials/research.
Ravi Shah, MD